The ImmunoSABR project is consortium of 15 partners which has been created from leading Institutes within the EU . Working together their aim is to open up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-modal curative treatment strategy.
STAY INFORMED ?
If you want to stay informed about ImmunoSABR project, please subscribe to our newsletter.
The D-Lab / Precision Medicine
P.O. Box 616,
6200 MD Maastricht, The Netherlands
This project has received funding from the European Union’s. Horizon 2020 research and innovation programme under grant agreement No 733008